Logan Capital Management Inc Pfizer Inc Transaction History

Logan Capital Management Inc

$2.24 Billion
Q2 2024

A detailed history of Logan Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Logan Capital Management Inc holds 565,385 shares of PFE stock, worth $16.4 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

565,385

Previous 573,887 1.48%

Holding current value

$16.4 Million

Previous $15.9 Million 0.67%

% of portfolio

0.71%

Previous 0.7%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $214,760 - $251,659	-8,502 Reduced 1.48%	565,385 $15.8 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $3.21 Million - $3.68 Million	123,878 Added 27.53%	573,887 $15.9 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1 Million - $1.3 Million	-38,448 Reduced 7.87%	450,009 $13 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.41 Million - $1.65 Million	44,067 Added 9.92%	488,457 $16.2 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $494,880 - $572,564	13,701 Added 3.18%	444,390 $16.3 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $919,126 - $1.2 Million	23,334 Added 5.73%	430,689 $17.6 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $24,423 - $31,882	-585 Reduced 0.14%	407,355 $20.9 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $140,294 - $171,264	3,206 Added 0.79%	407,940 $17.9 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $451,247 - $535,038	-9,698 Reduced 2.34%	404,734 $21.2 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $2.15 Million - $2.67 Million	-47,022 Reduced 10.19%	414,432 $21.5 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $530,962 - $787,062	-12,850 Reduced 2.71%	461,454 $27.2 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $1.65 Million - $2.12 Million	42,005 Added 9.72%	474,304 $20.4 Million
Q2 2021 Aug 17, 2021	SELL	$35.91 - $40.68 $163,785 - $185,541	-4,561 Reduced 1.04%	432,299 $16.9 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $47,723 - $53,822	-1,425 Reduced 0.33%	436,860 $15.8 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $1.48 Million - $1.88 Million	-44,276 Reduced 9.18%	438,285 $16.1 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $443,833 - $520,717	-13,979 Reduced 2.82%	482,561 $17.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $313,910 - $380,819	10,422 Added 2.14%	496,540 $16.2 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $136,204 - $194,606	-5,039 Reduced 1.03%	486,118 $15.9 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $991,122 - $1.12 Million	30,107 Added 6.53%	491,157 $19.2 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $20,143 - $26,120	620 Added 0.13%	461,050 $16.6 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $30,434 - $34,170	823 Added 0.18%	460,430 $19.9 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $427,837 - $470,050	-11,409 Reduced 2.42%	459,607 $19.5 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.55 Million - $1.77 Million	-40,255 Reduced 7.87%	471,016 $20.6 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $11,547 - $14,006	335 Added 0.07%	511,271 $22.5 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $63,552 - $67,753	-1,927 Reduced 0.38%	510,936 $18.5 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $175,217 - $203,276	5,491 Added 1.08%	512,863 $18.2 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $573,202 - $608,187	-17,234 Reduced 3.29%	507,372 $18.4 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $37,851 - $41,697	1,221 Added 0.23%	524,606 $18.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	523,385	523,385 $17.6 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account

Logan Capital Management Inc Pfizer Inc Transaction History